Adial Pharmaceuticals, Inc

Stage 2 · Advancing · week 8

As of Oct 22, 2026, Adial Pharmaceuticals is in Stage 2, the uptrend phase, now in week 8 (since Sep 1, 2026). It closed at $4.22, 55.6% below its 52-week high and above its 200-day average, which is falling.

$4.22

+2.68% today

$11.1M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 110 in Biotechnology · #1 of 272 in Health Care

Is ADIL early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 31w

S4 23w

S4 33w

S4 35w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 31w → S1 2w → S4 1w → S1 6w → S4 23w → S1 12w → S4 33w → S1 2w → S4 35w → S1 13w → S2 7w current

Total tracked: 166 weeks across 11 stage runs.

ADIL among Biotechnology364th of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…364	ADILAdial Pharmaceuticals, Inc	Stage 2 · wk 8	22	+4.5%

vs 52W High

-55.6%

$1.36 lo$9.50 hi

55.6% below 52W high

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 8

1w13w26w

Week 8, early Stage 2

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

28.9%

200 DMA: $3.27 · sloping down

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

0.04x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+4.5%

+51.8%

+170.5%

YTD

-29.7%

-53.1%

Scan Membership

Breakout Watch

Latest: 2021-06-08

4 appearances in last 60 days. First seen: 2020-01-21.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S2

Wk 8 · Vol 0.04x

2026-10-21S2

Wk 8 · Vol 0.41x

2026-10-20S2

Wk 7 · Vol 0.16x

2026-10-19S2

Wk 7 · Vol 0.22x

2026-10-16S2

Wk 7 · Vol 0.99x

2026-10-15S2

Wk 7 · Vol 0.24x

2026-10-14S2

Wk 7 · Vol 0.45x

2026-10-13S2

Wk 6 · Vol 1.23x

2026-10-12S2

Wk 6 · Vol 2.82x

2026-10-09S2

Wk 6 · Vol 0.05x

2026-10-08S2

Wk 6 · Vol 0.08x

2026-10-07S2

Wk 6 · Vol 0.07x

Moving averages & range

50 DMA

$4.80

200 DMA

$3.27

52W High

$9.50

52W Low

$1.36

5D Low

$3.49

Resistance levels (recent highs)

20d High

$4.35

60d High

$7.12

120d High

$7.12

250d High

$9.50

Next resistance

+3.1%

to 20d High

ROE

-2011.6%

Profit margin 0.0%

Dividend Yield

0.00%

P/B -0.3

Adial Pharmaceuticals: quick answers

What stage is Adial Pharmaceuticals in?

As of Oct 22, 2026, Adial Pharmaceuticals (ADIL) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 1, 2026 and is in week 8. What the four stages mean

Is Adial Pharmaceuticals in an uptrend?

Yes. Adial Pharmaceuticals is in a Stage 2 uptrend. It trades 28.9% above its 200-day average, which is falling.

How far is Adial Pharmaceuticals from its 52-week high?

Adial Pharmaceuticals closed at $4.22 on Oct 22, 2026, 55.6% below its 52-week high of $9.50. Its 52-week low is $1.36.

How has Adial Pharmaceuticals performed over the past year?

As of Oct 22, 2026, Adial Pharmaceuticals is down 53.1% over the past year and down 29.7% so far in 2026.

Which sector and industry is Adial Pharmaceuticals in?

Adial Pharmaceuticals is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.